Taiwan Advance Bio-Pharmaceutical Inc. (TPEX: 4186)
Health Care · Biotechnology · TW
NT$7.66
-11.85% today · -31.0% 1Y
Taiwan Advance Bio-Pharmaceutical Inc. (TPEX: 4186) operates in the Biotechnology industry within the Health Care sector. The company is valued at $21.65M and employs 160 people.
Over the last twelve months the share price has lost 31.0%, trading between 6.92 and 17.65.
Tweenvest scores Taiwan Advance Bio-Pharmaceutical Inc. across four factors: quality 66/100, value 43/100, growth 59/100. Its strongest factor is quality.
4186 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $21.65M
- Revenue (TTM)
- $10.96M
- P/E
- 42.35
- EPS
- 0.18
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- NT$17.65
- 52-week low
- NT$6.92
- Avg volume (3M)
- —
- Shares outstanding
- 90.00M
- Employees
- 160
- Next earnings
- —
About Taiwan Advance Bio-Pharmaceutical Inc.
Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.
- ISIN
- TW0004186002
- Founded
- 1989
- Listed since
- Nov 27, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.